Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01854138 · ClinicalTrials.gov registry record · NA
Evaluating Advantages of Prevena After Hip and Knee Arthroplasty
A NA study of Infection of Total Hip Joint Prosthesis, sponsored by ProMedica Health System.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT01854138: Completed NA study of Infection of Total Hip Joint Prosthesis, sponsored by ProMedica Health System.
NCT01854138 is a NA study of Infection of Total Hip Joint Prosthesis that has completed, run by ProMedica Health System. The registered enrollment target is 248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01854138, a NA study of Infection of Total Hip Joint Prosthesis, has completed, sponsored by ProMedica Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine the extent to which application of the Prevena vacuum system to clean surgical incisions immediately following surgical procedure (total hip or total knee arthroplasty) will reduce the rates of: * readmission to hospital for surgical intervention due to wound complications * seroma * hematoma * infection compared to group of patients whose wounds were covered with traditional gauze dressings.
Conditions Studied
Interventions
- DEVICE Prevena Incision Management System
Study Locations (1)
Ohio
- Wildwood Orthopaedic and Spine Hospital - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01854138 record still lists
NCT01854138 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Infection of Total Hip Joint Prosthesis appearing as the primary indexed condition, and to 1 intervention - of which Prevena Incision Management System is the first listed.
NCT01854138 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01854138 about?
NCT01854138 is a clinical study titled "Evaluating Advantages of Prevena After Hip and Knee Arthroplasty". Determine the extent to which application of the Prevena vacuum system to clean surgical incisions immediately following surgical procedure (total hip or total knee arthroplasty) will reduce the rates of: * readmission to hospital for surgical intervention due to wound complications * seroma * hema...
What is the current status of trial NCT01854138?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2014-01. Estimated completion is 2015-04.
What conditions does trial NCT01854138 study?
This clinical trial studies the following conditions: Infection of Total Hip Joint Prosthesis.
What interventions are being tested in trial NCT01854138?
The interventions under investigation include: Prevena Incision Management System (DEVICE).
Who is sponsoring clinical trial NCT01854138?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01854138 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01854138's enrollment target sits among peer trials
248 434th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia